Title |
Newer generation antidepressants for depressive disorders in children and adolescents
|
---|---|
Published in |
Cochrane database of systematic reviews, November 2012
|
DOI | 10.1002/14651858.cd004851.pub3 |
Pubmed ID | |
Authors |
Sarah E Hetrick, Joanne E McKenzie, Georgina R Cox, Magenta B Simmons, Sally N Merry |
Abstract |
Depressive disorders are common in young people and are associated with significant negative impacts. Newer generation antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), are often used, however evidence of their effectiveness in children and adolescents is not clear. Furthermore, there have been warnings against their use in this population due to concerns about increased risk of suicidal ideation and behaviour. |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 20% |
Mexico | 2 | 13% |
Canada | 1 | 7% |
Ireland | 1 | 7% |
Switzerland | 1 | 7% |
Australia | 1 | 7% |
United Kingdom | 1 | 7% |
Unknown | 5 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 9 | 60% |
Practitioners (doctors, other healthcare professionals) | 4 | 27% |
Scientists | 2 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 674 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | <1% |
Canada | 2 | <1% |
United Kingdom | 2 | <1% |
Norway | 1 | <1% |
Sweden | 1 | <1% |
Portugal | 1 | <1% |
Rwanda | 1 | <1% |
South Africa | 1 | <1% |
Unknown | 662 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 107 | 16% |
Student > Bachelor | 90 | 13% |
Researcher | 87 | 13% |
Student > Doctoral Student | 54 | 8% |
Student > Ph. D. Student | 50 | 7% |
Other | 128 | 19% |
Unknown | 158 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 206 | 31% |
Psychology | 102 | 15% |
Nursing and Health Professions | 46 | 7% |
Social Sciences | 25 | 4% |
Agricultural and Biological Sciences | 22 | 3% |
Other | 85 | 13% |
Unknown | 188 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 69. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 December 2023.
All research outputs
#621,378
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#1,126
of 11,499 outputs
Outputs of similar age
#3,268
of 192,725 outputs
Outputs of similar age from Cochrane database of systematic reviews
#25
of 241 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,725 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 241 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.